• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR Back to Search Results
Model Number G126
Device Problems Signal Artifact/Noise (1036); Premature Discharge of Battery (1057); Failure to Capture (1081); Over-Sensing (1438); Low impedance (2285); Defective Device (2588); Battery Problem (2885); Impedance Problem (2950)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2024
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited low out of range pace impedance measurements on the right atrial (ra) lead.As a result, a signal artifact monitor (sam) episode was stored with a vector switch.Boston scientific technical services (ts) also noted that noise was present on the ra as well as the right ventricular (rv) lead and left ventricular (lv) lead.Additionally, atrial signals were oversensed by the rv.According to the field presentative, an ra lead revision has been scheduled in the upcoming weeks.No adverse patient effects were reported.At this time, this device system remains in service.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.The associated investigation determined that this device exhibited intermittent impedance measurements with no conclusive evidence of a product performance issue or inadequate lead-to-device connection; please refer to the description for more information regarding the specific circumstances of this event.Investigation has determined that this type of event is likely the result of an intermittent high impedance condition associated with the device spring contact and lead terminal ring.A design enhancement was implemented in 2020 to stabilize the electrical connection between the spring contact and the lead terminal.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited low out of range pace impedance measurements on the right atrial (ra) lead.As a result, a signal artifact monitor (sam) episode was stored with a vector switch.Boston scientific technical services (ts) also noted that noise was present on the ra as well as the right ventricular (rv) lead and left ventricular (lv) lead.Additionally, atrial signals were oversensed by the rv.According to the field presentative, an ra lead revision has been scheduled in the upcoming weeks.Further information was received that a revision procedure was performed and the ra lead was surgically abandoned and replaced.Additional information was received that the battery of this device was suspected to be depleting prematurely.Ts calculated the battery longevity on current programmed settings and discussed it should be 8.5 years and the device is indicating 1.5 years to explant.Additionally, the power consumption of the device was found to be excessively high.A request was made to have data from this device analyzed.Data analysis confirmed the device to be malfunctioning in a manner consistent with a failure of the ra pacing channel.Multiple "leadimpcalnoise" daily ra measures, low ra measures and extreme power consumption were observed.Device replacement was recommended due to risk of damaging the pacing lead due to corrosion from current leakage.Upon further evaluation, the hcp suspected loss of capture (loc) in the newly implanted ra lead.Ts discussed testing it on the pacing system analyzer (psa) to determine if the issue was with the pg or if the lead had been damaged.A device changeout procedure was performed and it was confirmed the ra lead exhibited loc on this device, the psa and the new can, therefore, the physician explanted and replaced the ra lead and this device.No additional adverse patient effects were reported.This product has been received for analysis.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited low out of range pace impedance measurements on the right atrial (ra) lead.As a result, a signal artifact monitor (sam) episode was stored with a vector switch.Boston scientific technical services (ts) also noted that noise was present on the ra as well as the right ventricular (rv) lead and left ventricular (lv) lead.Additionally, atrial signals were oversensed by the rv.According to the field presentative, an ra lead revision has been scheduled in the upcoming weeks.Further information was received that a revision procedure was performed and the ra lead was surgically abandoned and replaced.No adverse patient effects were reported.At this time, this device system remains in service.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited low out of range pace impedance measurements on the right atrial (ra) lead.As a result, a signal artifact monitor (sam) episode was stored with a vector switch.Boston scientific technical services (ts) also noted that noise was present on the ra as well as the right ventricular (rv) lead and left ventricular (lv) lead.Additionally, atrial signals were oversensed by the rv.According to the field presentative, an ra lead revision has been scheduled in the upcoming weeks.Further information was received that a revision procedure was performed and the ra lead was surgically abandoned and replaced.Additional information was received that the battery of this device was suspected to be depleting prematurely.Ts calculated the battery longevity on current programmed settings and discussed it should be 8.5 years and the device is indicating 1.5 years to explant.Additionally, the power consumption of the device was found to be excessively high.A request was made to have data from this device analyzed.Data analysis confirmed the device to be malfunctioning in a manner consistent with a failure of the ra pacing channel.Multiple "leadimpcalnoise" daily ra measures, low ra measures and extreme power consumption were observed.Device replacement was recommended due to risk of damaging the pacing lead due to corrosion from current leakage.Upon further evaluation, the hcp suspected loss of capture (loc) in the newly implanted ra lead.Ts discussed testing it on the pacing system analyzer (psa) to determine if the issue was with the pg or if the lead had been damaged.A device changeout procedure was performed and it was confirmed the ra lead exhibited loc on this device, the psa and the new can, therefore, the physician explanted and replaced the ra lead and this device.No additional adverse patient effects were reported.It is expected to receive these products for analysis.The complaint device was not returned to boston scientific, therefore, product analysis could not be performed.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the product was performed.Review of device memory confirmed the presence of a higher-than-normal current drain condition.Electrical testing and analysis were then conducted, which isolated the high current to an anomaly in an oxide layer within a custom integrated circuit component.This anomaly caused a high current drain, which over time resulted in the reported clinical observations.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited low out of range pace impedance measurements on the right atrial (ra) lead.As a result, a signal artifact monitor (sam) episode was stored with a vector switch.Boston scientific technical services (ts) also noted that noise was present on the ra as well as the right ventricular (rv) lead and left ventricular (lv) lead.Additionally, atrial signals were oversensed by the rv.According to the field presentative, an ra lead revision has been scheduled in the upcoming weeks.Further information was received that a revision procedure was performed and the ra lead was surgically abandoned and replaced.Additional information was received that the battery of this device was suspected to be depleting prematurely.Ts calculated the battery longevity on current programmed settings and discussed it should be 8.5 years and the device is indicating 1.5 years to explant.Additionally, the power consumption of the device was found to be excessively high.A request was made to have data from this device analyzed.Data analysis confirmed the device to be malfunctioning in a manner consistent with a failure of the ra pacing channel.Multiple "leadimpcalnoise" daily ra measures, low ra measures and extreme power consumption were observed.Device replacement was recommended due to risk of damaging the pacing lead due to corrosion from current leakage.Upon further evaluation, the hcp suspected loss of capture (loc) in the newly implanted ra lead.Ts discussed testing it on the pacing system analyzer (psa) to determine if the issue was with the pg or if the lead had been damaged.A device changeout procedure was performed and it was confirmed the ra lead exhibited loc on this device, the psa and the new can, therefore, the physician explanted and replaced the ra lead and this device.No additional adverse patient effects were reported.This product has been received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18678157
MDR Text Key335220012
Report Number2124215-2024-07592
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589140
UDI-Public00802526589140
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/14/2024
Device Model NumberG126
Device Catalogue NumberG126
Device Lot Number106419
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received04/30/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age79 YR
Patient SexMale
-
-